Tavani A - Search Results

1

Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels.

Peracchia F, Bianchi G, Fiocchi R, Petrillo P, Tavani A, Manara L. Peracchia F, et al. Among authors: tavani a. J Pharm Pharmacol. 1984 Oct;36(10):699-701. doi: 10.1111/j.2042-7158.1984.tb04850.x. J Pharm Pharmacol. 1984. PMID: 6150093

2

Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats.

Tavani A, Bianchi G, Manara L. Tavani A, et al. Eur J Pharmacol. 1979 Oct 26;59(1-2):151-4. doi: 10.1016/0014-2999(79)90039-6. Eur J Pharmacol. 1979. PMID: 510395

3

Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.

Manara L, Bianchi G, Ferretti P, Tavani A. Manara L, et al. Among authors: tavani a. J Pharmacol Exp Ther. 1986 Jun;237(3):945-9. J Pharmacol Exp Ther. 1986. PMID: 3012075

4

The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.

Bianchi G, Fiocchi R, Peracchia F, Petrillo P, Tavani A, Manara L. Bianchi G, et al. Among authors: tavani a. J Pharm Pharmacol. 1984 May;36(5):326-30. doi: 10.1111/j.2042-7158.1984.tb04384.x. J Pharm Pharmacol. 1984. PMID: 6145770

5

Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.

Tavani A, Petrillo P, La Regina A, Sbacchi M. Tavani A, et al. J Pharmacol Exp Ther. 1990 Jul;254(1):91-7. J Pharmacol Exp Ther. 1990. PMID: 2164103

6

The opioid kappa-selective compound U-50,488H does not inhibit intestinal propulsion in rats.

Tavani A, Gambino MC, Petrillo P. Tavani A, et al. J Pharm Pharmacol. 1984 May;36(5):343-4. doi: 10.1111/j.2042-7158.1984.tb04391.x. J Pharm Pharmacol. 1984. PMID: 6145777

7

Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog.

Manara L, Bianchi G, Fiocchi R, Notarnicola A, Peracchia F, Tavani A. Manara L, et al. Among authors: tavani a. Life Sci. 1982 Sep 20-27;31(12-13):1271-4. doi: 10.1016/0024-3205(82)90359-9. Life Sci. 1982. PMID: 6183550

8

Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut.

Bianchi G, Ferretti P, Recchia M, Rocchetti M, Tavani A, Manara L. Bianchi G, et al. Among authors: tavani a. Gastroenterology. 1983 Oct;85(4):852-8. Gastroenterology. 1983. PMID: 6193028

9

Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity.

Bianchi G, Fiocchi R, Tavani A, Manara L. Bianchi G, et al. Among authors: tavani a. Life Sci. 1982 May 31;30(22):1875-83. doi: 10.1016/0024-3205(82)90467-2. Life Sci. 1982. PMID: 7109826

10

Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine.

Fiocchi R, Bianchi G, Petrillo P, Tavani A, Manara L. Fiocchi R, et al. Among authors: tavani a. Life Sci. 1982 Nov 15-22;31(20-21):2221-3. doi: 10.1016/0024-3205(82)90123-0. Life Sci. 1982. PMID: 7162339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters